Biotech Values

[jq1234]

It's funny when we blame Goldman for pointing out the clouds overhanging this stock

Who blamed Goldman for pointing out the clouds overhanging this stock? This had been pointed out on this board repeatedly that tlovenox was/is the key reason overhanging over MNTA stock. You were one of few who were slow to realize this by looking everything else under the rock for why MNTA stock price had been where it had been when everyone else had realized this. Fortunately you came around.

Nothing in Goldman report is new. Again, you typically miss the point again. We simply blamed Goldman report's inconsistency. If they had stated they didn't know when tlovonex would be approved (I don't fault people who hold this opinion), then the report would be consistent. To say they don't expect tlovenox to be approved for many years, then turn around say $15 is fair value is inconsistent. You found comfort in the report because it is Goldman even though almost every single key point in the report had been hashed and rehashed on this board a zillion times over.

I am willing to bet against anyone, Goldman included, that if tlovenox is not approved for two more years, MNTA stock is going to be significantly higher than $15.